The North America biotechnology market, valued at approximately USD 710.93 billion in 2025, is projected to grow significantly, reaching approximately USD 2.17 trillion by 2035, with a compound annual growth rate (CAGR) of 11.80% from 2026 to 2035. Despite facing regulatory challenges, funding issues, and complex clinical trial processes, industry leaders remain optimistic, emphasizing collaboration and innovative technologies like AI and advanced drug delivery systems.
Key findings from a recent survey of biotechnology executives indicate that while challenges such as regulatory uncertainty and workforce limitations persist, over 97% of leaders prioritize patient-centered approaches. The U.S. continues to dominate the market, with Canada anticipated to exhibit the fastest growth rate. Additionally, segments such as monoclonal antibodies, genomics, and diagnostics are expected to be pivotal for future growth in the sector.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.biospace.com/press-releases/north-america-biotechnology-market-to-capture-usd-2168-91-billion-by-2035
